Exact Sciences Corp

More Details of Company

Company Info

Ticker SymbolEXAS

Company nameExact Sciences Corp

IPO dateJan 30, 2001

CEOMr. Kevin T. Conroy

Number of employees6900

Security typeOrdinary Share

Fiscal year-endJan 30

Address5505 Endeavor Lane

CityMADISON

Stock exchangeNASDAQ Capital Market Consolidated

CountryUnited States of America

Postal code53719

Phone16082845700

Websitehttps://www.exactsciences.com/

Ticker SymbolEXAS

IPO dateJan 30, 2001

CEOMr. Kevin T. Conroy

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Kevin T. Conroy

Chairman of the Board, President, Chief Executive Officer

1.14M

-20.54%

Ms. Katherine S. (Kay) Zanotti

Independent Director

72.76K

+3.10%

Mr. Daniel J. (Dan) Levangie

Independent Director

34.31K

+18.67%

Ms. Shacey Petrovic

Independent Director

28.90K

+22.97%

Mr. Brian Baranick

Executive Vice President, General Manager - Precision Oncology

25.90K

+11.32%

Ms. Leslie L. Trigg

Independent Director

17.17K

+80.75%

Ms. Kimberly J. (Kim) Popovits

Independent Director

16.38K

+156.47%

Mr. Aaron Bloomer

Chief Financial Officer, Executive Vice President

13.84K

--

Mr. Michael J. (Mike) Barber, M.D.

Independent Director

13.14K

+121.18%

Mr. James E. Doyle

Lead Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. Kevin T. Conroy

Chairman of the Board, President, Chief Executive Officer

1.14M

-20.54%

Ms. Katherine S. (Kay) Zanotti

Independent Director

72.76K

+3.10%

Mr. Daniel J. (Dan) Levangie

Independent Director

34.31K

+18.67%

Ms. Shacey Petrovic

Independent Director

28.90K

+22.97%

Mr. Brian Baranick

Executive Vice President, General Manager - Precision Oncology

25.90K

+11.32%

Ms. Leslie L. Trigg

Independent Director

17.17K

+80.75%

Revenue Breakdown

Currency: USDUpdated: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Commercial

332.50M

47.04%

Medicare Parts B & C

247.89M

35.07%

Other

74.81M

10.58%

International

51.59M

7.30%

By RegionUSD

Name

Revenue

Proportion

United States (Country)

655.20M

92.70%

Outside of united states

51.59M

7.30%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Commercial

332.50M

47.04%

Medicare Parts B & C

247.89M

35.07%

Other

74.81M

10.58%

International

51.59M

7.30%

Shareholding Stats

Updated: Sat, Aug 16

Shareholders

Shareholder Types

Shareholders

Proportion

Fidelity Management & Research Company LLC

12.30%

Capital World Investors

9.61%

The Vanguard Group, Inc.

9.44%

Wellington Management Company, LLP

6.34%

BlackRock Institutional Trust Company, N.A.

3.72%

Other

58.59%

Shareholders

Proportion

Fidelity Management & Research Company LLC

12.30%

Capital World Investors

9.61%

The Vanguard Group, Inc.

9.44%

Wellington Management Company, LLP

6.34%

BlackRock Institutional Trust Company, N.A.

3.72%

Other

58.59%

Shareholder Types

Shareholders

Proportion

Investment Advisor

56.40%

Investment Advisor/Hedge Fund

27.98%

Hedge Fund

6.47%

Research Firm

2.05%

Pension Fund

0.94%

Individual Investor

0.92%

Bank and Trust

0.69%

Sovereign Wealth Fund

0.48%

Private Equity

0.32%

Other

3.76%

Institutional Shareholding

Updated: Tue, Jul 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q2

1403

202.48M

106.98%

+2.53M

2025Q1

1424

199.78M

106.03%

-445.52K

2024Q4

1411

200.72M

108.09%

-225.66K

2024Q3

1375

190.82M

103.28%

-5.17M

2024Q2

1358

185.25M

100.40%

+6.59M

2024Q1

1347

168.41M

92.78%

-6.10M

2023Q4

1356

165.31M

91.41%

-11.01M

2023Q3

1337

167.70M

92.83%

-6.22M

2023Q2

1354

166.38M

92.24%

-10.65M

2023Q1

1343

167.01M

92.90%

-8.56M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

Fidelity Management & Research Company LLC

24.14M

12.8%

+5.29M

+28.03%

Mar 31, 2025

Capital World Investors

17.84M

9.45%

+297.66K

+1.70%

Mar 31, 2025

The Vanguard Group, Inc.

17.56M

9.31%

+616.59K

+3.64%

Mar 31, 2025

Wellington Management Company, LLP

12.50M

6.63%

+442.78K

+3.67%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

7.68M

4.07%

+12.62K

+0.16%

Mar 31, 2025

State Street Global Advisors (US)

6.61M

3.51%

+381.12K

+6.11%

Mar 31, 2025

Fidelity Institutional Asset Management

3.59M

1.9%

+1.68M

+88.60%

Mar 31, 2025

T. Rowe Price Associates, Inc.

6.25M

3.32%

+631.23K

+11.22%

Mar 31, 2025

Geode Capital Management, L.L.C.

3.27M

1.73%

+143.64K

+4.60%

Mar 31, 2025

Related ETFs

Updated: Sat, Sep 6

Name

Proportion

Calvert US Select Equity ETF

0%

iShares MSCI USA Equal Weighted ETF

0%

Fidelity Momentum Factor ETF

0%

Zacks Small/Mid Cap ETF

0%

JPMorgan US Momentum Factor ETF

0%

iShares ESG Aware MSCI USA ETF

0%

Amplify AI Powered Equity ETF

0%

Goldman Sachs ActiveBeta US Large Cap Equity ETF

0%

Inspire Global Hope ETF

0%

Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF

0%

Calvert US Select Equity ETF

Proportion0%

iShares MSCI USA Equal Weighted ETF

Proportion0%

Fidelity Momentum Factor ETF

Proportion0%

Zacks Small/Mid Cap ETF

Proportion0%

JPMorgan US Momentum Factor ETF

Proportion0%

iShares ESG Aware MSCI USA ETF

Proportion0%

Amplify AI Powered Equity ETF

Proportion0%

Goldman Sachs ActiveBeta US Large Cap Equity ETF

Proportion0%

Inspire Global Hope ETF

Proportion0%

Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF

Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

53.570USD

Exact Sciences Corp

53.570

Overview

Company

Financials

Analysis